Cite
HARVARD Citation
Ri, M. et al. (2022). Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort. Cancer science. 113 (12), pp. 4267-4276. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ri, M. et al. (2022). Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort. Cancer science. 113 (12), pp. 4267-4276. [Online].